Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable. Nanowear offers home-based, AI-enabled digital diagnostics…
Continue Reading
Amboss, a medical education company for medical students and healthcare stakeholders, closed a €240 million ($259.44 million) financing round.The round included new primary investors KIRKBI, M&G Investments and Lightrock, with participation from existing shareholders….
Continue Reading
Drug discovery startup Insilico Medicine and Italian pharmaceutical company Menarini Group announced their second licensing agreement, targeting unmet needs in oncology with a novel AI-discovered preclinical asset. The agreement grants Stemline Therapeutics, a subsidiary of…
Continue Reading
Digital Healthcare company WELL Health Technologies Corp. entered into definitive agreements to acquire the clinical assets of Jack Nathan Medical Corp., which includes a network of 16 owned and operated primary care clinics across…
Continue Reading
Google announced it is licensing its AI model focused on detecting diabetic retinopathy to partners in Thailand and India, two countries the tech giant says have a shortage of eye specialists. Google Research teams partnered…
Continue Reading
NHS Shared Business Services (NHS SBS) has published a contract notice for the Digital Workplace Solutions 2 framework, worth £2.5 billion.
The framework is intended to connect NHS organisations and public sector buyers that wish…
What You Should Know:
– ALZpath, a leader in Alzheimer’s disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer’s disease…
Continue Reading
What You Should Know: – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific…
Continue Reading
What You Should Know:
– G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific region)…
Continue Reading
IQVIA, a global provider of advanced analytics, clinical research services and technology solutions, announced it has expanded its partnership with tech company Salesforce to help expand its customer engagement platform for the life sciences…
Continue Reading
